| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 0 | 8.367 | 27.825 | 38.957 | 39.407 | 59.332 | 91.709 |
| Total Income - EUR | - | - | 402 | 4.736 | 15.670 | 40.916 | 41.890 | 43.221 | 63.138 | 94.549 |
| Total Expenses - EUR | - | - | 676 | 12.342 | 22.240 | 29.103 | 34.835 | 38.640 | 36.955 | 89.169 |
| Gross Profit/Loss - EUR | - | - | -275 | -7.606 | -6.570 | 11.813 | 7.055 | 4.581 | 26.182 | 5.379 |
| Net Profit/Loss - EUR | - | - | -275 | -7.606 | -6.654 | 11.555 | 6.665 | 4.229 | 25.662 | 2.910 |
| Employees | - | - | 0 | 1 | 2 | 2 | 2 | 1 | 2 | 2 |
Check the financial reports for the company - Ad Biodentis Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 34.453 | 29.085 | 23.935 | 19.597 | 15.916 | 13.186 | 11.348 | 160.920 |
| Current Assets | - | - | 48.510 | 7.923 | 7.007 | 9.704 | 16.083 | 19.549 | 24.026 | 18.293 |
| Inventories | - | - | 4.678 | 4.698 | 5.029 | 5.212 | 5.746 | 7.586 | 10.061 | 13.051 |
| Receivables | - | - | 43.781 | 55 | 518 | 53 | 53 | 1.216 | 2.353 | 52 |
| Cash | - | - | 51 | 3.169 | 1.460 | 4.438 | 10.283 | 10.746 | 11.612 | 5.190 |
| Shareholders Funds | - | - | -231 | -7.833 | -14.336 | -2.509 | 4.212 | 8.454 | 34.091 | 36.799 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 39.815 | 6.994 | 12.807 | 4.510 | 4.020 | 4.250 | 16.329 | 129.166 |
| Income in Advance | - | - | 43.379 | 37.847 | 32.470 | 27.299 | 23.766 | 20.031 | 16.172 | 13.248 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Ad Biodentis Srl